A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
Clinical trial NCT06267846 · COMPLETED
Trial details
- NCT number
- NCT06267846
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2025-07-25
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.